{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:46:24Z","timestamp":1777956384854,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AI programme of the Engineering and Physical Sciences Research Council","award":["EP\/Y028392\/1"],"award-info":[{"award-number":["EP\/Y028392\/1"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["ACF-2015-25-002"],"award-info":[{"award-number":["ACF-2015-25-002"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pneumococcal surveillance typically focuses on cases identified by positive microbiology and collects limited clinical data. The majority of pneumococcal studies in the literature focus on invasive respiratory disease. This study includes a cohort of all cause pneumococcal disease, including non-invasive disease and non-respiratory invasive disease with detailed clinical outcomes, allowing a more complete view of pneumococcal disease burden, and particularly meningitis cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A longitudinal adult cohort of invasive and non-invasive pneumococcal disease inpatients in three hospitals between 2006 and 2022, was retrospectively collected. The demographics and outcomes of invasive and non-invasive hospitalised cases were compared. Features of invasive disease in different clinical presentations, particularly meningitis, were compared to invasive respiratory disease. Serotype distributions of different presentations in invasive disease were compared using bootstrap resampling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of a total 3719 all cause pneumococcal disease, 1419 cases (38.2%) were invasive respiratory disease. Non-invasive disease was seen in 2033 cases (54.7%). Non-invasive disease had a lower (but clinically substantial) 30\u00a0day case-fatality rate than invasive disease (11.7% versus 14.8%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005), and similar lengths of stay in hospital. Among the 1686 invasive cases, 258 (15.3%) were outside the respiratory tract. The 172 cases presenting with meningitis were younger (54.9y vs. 66.8y;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) than those with lower respiratory tract infection; and had high rates of intensive care admission (63.4% vs. LRTI 10.2%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). We found no evidence of a different serotype distribution between different clinical presentations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There is a substantial burden of pneumococcal disease that is not represented by studies that focus on invasive respiratory disease, or by surveillance that focus only on culture positive disease alone. Outcomes are particularly poor in the case of meningitis, but non-invasive disease also has a high case fatality rate. Given the same serotypes are found in meningitis as invasive respiratory disease, we anticipate that the same vaccines that target respiratory disease should be relevant to the prevention of meningitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13122-y","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:36:14Z","timestamp":1774517774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in invasive and non-invasive Streptococcus pneumoniae disease in adults hospitalised in Bristol and Bath: a retrospective cohort study, 2006\u20132022"],"prefix":"10.1186","volume":"26","author":[{"given":"Robert","family":"Challen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Hyams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hettle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahin","family":"Amin-Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charli","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Ruffino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rauri","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"North","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Malin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick A.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. Martin","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamez N.","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Danon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"13122_CR1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SRM, et al. Estimates of the Global, Regional, and National Morbidity, Mortality, and Aetiologies of Lower Respiratory Infections in 195 Countries, 1990\u20132016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18:1191\u2013210.","journal-title":"Lancet Infect Dis"},{"key":"13122_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","volume":"16","author":"JN Weiser","year":"2018","unstructured":"Weiser JN, Ferreira DM, Paton JC. Streptococcus Pneumoniae: Transmission, Colonization and Invasion. Nat Rev Microbiol. 2018;16:355\u201367.","journal-title":"Nat Rev Microbiol"},{"key":"13122_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/geriatrics6010013","volume":"6","author":"RE Thomas","year":"2021","unstructured":"Thomas RE. Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and Mortality. Geriatrics. 2021;6:13.","journal-title":"Geriatrics"},{"key":"13122_CR4","unstructured":"Pneumococcal Disease. Guidance, Data and Analysis. GOV.UK.; 2015."},{"key":"13122_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","volume":"18","author":"SN Ladhani","year":"2018","unstructured":"Ladhani SN, Collins S, Djennad A, Sheppard CL, Borrow R, Fry NK, et al. Rapid Increase in Non-Vaccine Serotypes Causing Invasive Pneumococcal Disease in England and Wales, 2000\u201317: A Prospective National Observational Cohort Study. Lancet Infect Dis. 2018;18:441\u201351.","journal-title":"Lancet Infect Dis"},{"key":"13122_CR6","first-page":"760","volume":"11","author":"E Miller","year":"2011","unstructured":"Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd Immunity and Serotype Replacement 4 Years after Seven-Valent Pneumococcal Conjugate Vaccination in England and Wales: An Observational Cohort Study. The Lancet. Infect Dis. 2011;11:760\u20138.","journal-title":"Infect Dis"},{"key":"13122_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3201\/eid2801.210734","volume":"28","author":"G Hanquet","year":"2022","unstructured":"Hanquet G, Krizova P, Dalby T, Ladhani SN, Nuorti JP, Danis K, et al. Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe. Emerg Infect Dis. 2022;28:137\u20138.","journal-title":"Emerg Infect Dis"},{"key":"13122_CR8","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1086\/374624","volume":"187","author":"AB Brueggemann","year":"2003","unstructured":"Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal Relationships between Invasive and Carriage Streptococcus Pneumoniae and Serotype- and Clone-Specific Differences in Invasive Disease Potential. J Infect Dis. 2003;187:1424\u201332.","journal-title":"J Infect Dis"},{"key":"13122_CR9","doi-asserted-by":"crossref","unstructured":"Oligbu G, Collins S, Djennad A, Sheppard CL, Fry NK, Andrews NJ et al. Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000\u2013June 30, 2016. Emerg Infect Dis. 2019;25.","DOI":"10.3201\/eid2509.180747"},{"key":"13122_CR10","doi-asserted-by":"publisher","first-page":"100692","DOI":"10.1016\/j.lanepe.2023.100692","volume":"32","author":"S Subbarao","year":"2023","unstructured":"Subbarao S, Ribeiro S, Campbell H, Okike I, Ramsay ME, Ladhani SN. Trends in Laboratory-Confirmed Bacterial Meningitis (2012\u20132019): National Observational Study, England. Lancet Reg Health - Europe. 2023;32:100692.","journal-title":"Lancet Reg Health - Europe"},{"key":"13122_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/cid\/ciab477","volume":"74","author":"DLH Koelman","year":"2022","unstructured":"Koelman DLH, Brouwer MC, Ter Horst L, Bijlsma MW, van der Ende A, van de Beek D. Pneumococcal Meningitis in Adults: A Prospective Nationwide Cohort Study Over a 20-Year Period. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2022;74:657\u201367.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"13122_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"W Lim","year":"2003","unstructured":"Lim W, van der Eerden MM, Laing R, Boersma W, Karalus N, Town G, et al. Defining Community Acquired Pneumonia Severity on Presentation to Hospital: An International Derivation and Validation Study. Thorax. 2003;58:377.","journal-title":"Thorax"},{"key":"13122_CR13","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","volume":"64","author":"WS Lim","year":"2009","unstructured":"Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Jeune IL, et al. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults: Update 2009. Thorax. 2009;64:iii1\u201355.","journal-title":"Thorax"},{"key":"13122_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1214\/ss\/1009213286","volume":"16","author":"LD Brown","year":"2001","unstructured":"Brown LD, Cai TT, DasGupta A. Interval Estimation for a Binomial Proportion. Stat Sci. 2001;16:101\u201333.","journal-title":"Stat Sci"},{"key":"13122_CR15","doi-asserted-by":"crossref","unstructured":"Fisher RA, Yates F, Statistical Methods E, Design, Inference S. A Re-issue of Statistical methods for research workers, The design of experiments, and statistical methods and scientific inference. 1st edition. Bennett JH, editor. Oxford England; New York: Oxford University Press; 1990.","DOI":"10.1093\/oso\/9780198522294.003.0001"},{"key":"13122_CR16","unstructured":"Cox DR, Oakes D. Analysis of Survival Data. Volume 21. CRC; 1984."},{"key":"13122_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/b98858","volume-title":"Local Regression and Likelihood","author":"C Loader","year":"1999","unstructured":"Loader C. Local Regression and Likelihood. New York: Springer-; 1999. (Statistics and Computing)."},{"key":"13122_CR18","doi-asserted-by":"crossref","unstructured":"Hyams C, Challen R, Begier E, Southern J, King J, Morley A, et al. Incidence of Community Acquired Lower Respiratory Tract Disease in Bristol, UK during the COVID-19 Pandemic: A Prospective Cohort Study. Volume 21. The Lancet Regional Health \u2013 Europe; 2022.","DOI":"10.2139\/ssrn.4087373"},{"key":"13122_CR19","doi-asserted-by":"crossref","unstructured":"Hyams C, Challen R, Hettle D, Amin-Chowdhury Z, Grimes C, Ruffino G et al. Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus Pneumoniae Infection, Bristol and Bath, UK, 2006\u20132022. Emerg Infect Dis. 2023;29.","DOI":"10.3201\/eid2910.230519"},{"key":"13122_CR20","volume-title":"R: A Language and Environment for Statistical Computing","author":"RC Team","year":"2017","unstructured":"Team RC. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2017."},{"key":"13122_CR21","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.21105\/joss.04707","volume":"7","author":"R Challen","year":"2022","unstructured":"Challen R, Dtrackr. An R Package for Tracking the Provenance of Data. J Open Source Softw. 2022;7:4707.","journal-title":"J Open Source Softw"},{"key":"13122_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cmi.2019.04.032","volume":"26","author":"DLH Koelman","year":"2020","unstructured":"Koelman DLH, Brouwer MC, van de Beek D. Resurgence of Pneumococcal Meningitis in Europe and Northern America. Clin Microbiol Infect. 2020;26:199\u2013204.","journal-title":"Clin Microbiol Infect"},{"key":"13122_CR23","doi-asserted-by":"publisher","first-page":"e015080","DOI":"10.1136\/bmjopen-2016-015080","volume":"7","author":"A Polkowska","year":"2017","unstructured":"Polkowska A, Toropainen M, Ollgren J, Lyytik\u00e4inen O, Nuorti JP. Bacterial Meningitis in Finland, 1995\u20132014: A Population-Based Observational Study. BMJ Open. 2017;7:e015080.","journal-title":"BMJ Open"},{"key":"13122_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12879-015-0787-1","volume":"15","author":"M Im\u00f6hl","year":"2015","unstructured":"Im\u00f6hl M, M\u00f6ller J, Reinert RR, Perniciaro S, van der Linden M, Aktas O. Pneumococcal Meningitis and Vaccine Effects in the Era of Conjugate Vaccination: Results of 20 Years of Nationwide Surveillance in Germany. BMC Infect Dis. 2015;15:61.","journal-title":"BMC Infect Dis"},{"key":"13122_CR25","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1016\/j.vaccine.2016.07.038","volume":"34","author":"S Ben-Shimol","year":"2016","unstructured":"Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Miron D, Aviner S, et al. Impact of PCV7\/PCV13 Introduction on Invasive Pneumococcal Disease (IPD) in Young Children: Comparison between Meningitis and Non-Meningitis IPD. Vaccine. 2016;34:4543\u201350.","journal-title":"Vaccine"},{"key":"13122_CR26","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.1016\/j.vaccine.2017.09.050","volume":"35","author":"DM Jacobs","year":"2017","unstructured":"Jacobs DM, Yung F, Hart E, Nguyen MNH, Shaver A. Trends in Pneumococcal Meningitis Hospitalizations Following the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in the United States. Vaccine. 2017;35:6160\u20135.","journal-title":"Vaccine"},{"key":"13122_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine. J Infect Dis. 2010;201:32\u201341.","journal-title":"J Infect Dis"},{"key":"13122_CR28","doi-asserted-by":"crossref","unstructured":"Alexandre C, Dubos F, Courouble C, Pruvost I, Varon E et al. for Evaluating the management of common childhood diseases HN,. Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement. Acta Paediatrica (Oslo, Norway: 1992). 2010;99:1686\u201390.","DOI":"10.1111\/j.1651-2227.2010.01914.x"},{"key":"13122_CR29","unstructured":"Pneumococcal. The Green Book, Chap. 25. UK Health Security Agency; 2013Mar p. 13. Report No.: PHE gateway number 2019220."},{"key":"13122_CR30","first-page":"13","volume":"10","author":"WS Lim","year":"2019","unstructured":"Lim WS, Lawrence H. National Adult Community Acquired Pneumonia Audit 2018\/19. Br Thorac Soc Rep. 2019;10:13.","journal-title":"Br Thorac Soc Rep"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13122-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13122-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13122-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:10:32Z","timestamp":1777947032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13122-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13122"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13122-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Health Research Authority, UK (IRAS 265437). The study was conducted using data collected retrospectively from the routine care record by the direct care team, and deidentified for analysis. At the point of analysis the data is not considered personal, and review by a research ethics committee and consent to participate was deemed unnecessary by national legislation (UK GDPR and Data Protection Act 2018). The study adhered to the Declaration of Helsinki (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CH is Principal Investigator of the AvonCAP study which is an investigator-led University of Bristol study funded by Pfizer. AF was until January 2024 a member of the Joint Committee on Vaccination and Immunization (JCVI) and was, until December 2022, chair of the World Health Organization European Technical Advisory Group of Experts on Immunization (ETAGE) committee. In addition to receiving funding from Pfizer as Chief Investigator of the AvonCAP study, he leads another project investigating transmission of respiratory bacteria in families jointly funded by Pfizer and the Gates Foundation. The other authors have no relevant conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"898"}}